AGS<3 beginning
AGS ≥ 3 advanced
%
total
36
13
100
no progression
24
8
65.3
progression
12
5
34.7
%
73.5
26.5
Table 1:
Distribution of NTG patients according to qualitative perimetric results (Aulhorn glaucoma stages AGS); beginning (AGS<3) and advanced stages (AGS≥3); progressive and nonprogressive disease (n).
